Otros

Únete a nuestro

EN

Atrás



healthcare: pharmaNoticias

Para usted Mercados Economía Tecnología e IA Criptomoneda Energía Atención médica Hong Kong y China Finanzas

Farmacéutico

Biotecnología

Servicios de salud

Dispositivos médicos

BioMarin beats Q2 estimates, lifts 2026 outlook on 20% revenue growth

BioMarin beats Q2 estimates, lifts 2026 outlook on 20% revenue growth

Aug 07 2026, 17:08

TransThera shares jump 14% on China approval of tinengotinib

TransThera shares jump 14% on China approval of tinengotinib

Aug 07 2026, 03:35

FDA approves Replimune's Tudriqev melanoma drug after two rejections

FDA approves Replimune's Tudriqev melanoma drug after two rejections

Aug 07 2026, 03:25

Hikma jumps 10% as H1 profit beats, brokers keep buy

Hikma jumps 10% as H1 profit beats, brokers keep buy

Aug 06 2026, 10:06

BeOne Medicines lifts 2026 outlook as Brukinsa sales jump 31%

BeOne Medicines lifts 2026 outlook as Brukinsa sales jump 31%

Aug 06 2026, 05:28

Moderna wins FDA approval for mFLUSIVA flu vaccine in adults 50+

Moderna wins FDA approval for mFLUSIVA flu vaccine in adults 50+

Aug 06 2026, 02:49

FDA approves Takeda's oveporexton, first orexin agonist for narcolepsy type 1

FDA approves Takeda's oveporexton, first orexin agonist for narcolepsy type 1

Aug 05 2026, 22:16

Lilly raises 2026 guidance as Mounjaro, Zepbound drive 48% revenue jump

Lilly raises 2026 guidance as Mounjaro, Zepbound drive 48% revenue jump

Aug 05 2026, 11:41

Gilead Q2 revenue jumps 10% as PrEP sales top $1 billion

Gilead Q2 revenue jumps 10% as PrEP sales top $1 billion

Aug 05 2026, 02:48

Novo Nordisk raises 2026 outlook after Q2 profit jumps 11%

Novo Nordisk raises 2026 outlook after Q2 profit jumps 11%

Aug 04 2026, 16:54

CRISPR Therapeutics narrows Q2 loss as Casgevy sales surge 151%

CRISPR Therapeutics narrows Q2 loss as Casgevy sales surge 151%

Aug 04 2026, 16:19

Merck raises 2026 sales forecast to $67.3B, cuts profit view

Merck raises 2026 sales forecast to $67.3B, cuts profit view

Aug 04 2026, 11:16

Regeneron faces securities suit after $11 billion melanoma trial wipeout

Regeneron faces securities suit after $11 billion melanoma trial wipeout

Aug 04 2026, 01:21

Zevra Therapeutics falls 25% as EMA rejects arimoclomol in NPC re-examination

Zevra Therapeutics falls 25% as EMA rejects arimoclomol in NPC re-examination

Aug 03 2026, 14:23

Ascletis starts Phase III obesity trial enrolling 4,600 patients

Ascletis starts Phase III obesity trial enrolling 4,600 patients

Aug 03 2026, 13:58

AstraZeneca, Bristol Myers Squibb in talks on $400 billion merger

AstraZeneca, Bristol Myers Squibb in talks on $400 billion merger

Aug 03 2026, 07:50

Sandoz settles $450 million antitrust claims with 43 US states

Sandoz settles $450 million antitrust claims with 43 US states

Aug 03 2026, 06:25

Novo Nordisk claws back into obesity race as shares climb 35%

Novo Nordisk claws back into obesity race as shares climb 35%

Aug 03 2026, 05:51

FDA approves Novartis Pluvicto, cutting prostate cancer progression risk 33%

FDA approves Novartis Pluvicto, cutting prostate cancer progression risk 33%

Jul 31 2026, 23:48

Pharming shares plunge 22% as RUCONEST sales slide 10%

Pharming shares plunge 22% as RUCONEST sales slide 10%

Jul 31 2026, 22:45

Características

Copiloto de IA para Acciones y Criptomonedas

Predicción de precios

Seguimiento de Recaudación de Fondos

Comparación de Criptomonedas

Página de inicio

Markets

News

AI & Technology

Términos de uso Política de privacidad Mapa del sitio

© 2026 Edgen impulsado por